{
  "trial_id": "NCT02468648",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "HCV RNA greater than or equal to10^4 IU/mL at Screening",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "HCV genotypes 1a, 1b, 2, 3 or 4 at screening",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Confirmation of chronic HCV infection documented by either: A positive anti-HCV antibody test or positive HCV RNA or positive HCV genotyping test at least 6 months prior to the Baseline/Day 1 visit, or A liver biopsy performed within 12 weeks prior to the Baseline/Day 1 visit with evidence of chronic HCV infection.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Screening ECG without clinically significant abnormalities",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ALT less than or equal to 10 times the upper limit of normal (ULN)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "AST less than or equal to 10 times ULN",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Direct bilirubin less than or equal to 1.5 ULN",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Platelets > 70,000",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "HbA1c less than or equal to8.5%",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "eGFR greater than or equal to 60 mL /min, as calculated by the CKD-EPI equation.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Hemoglobin greater than or equal to 10g/dL",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Albumin greater than or equal to 3g/dL",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Current or prior history of any of the following: Clinically-significant illness (other than HCV) or any other major medical disorder that may interfere with subject treatment, assessment or compliance with the protocol; subjects currently under evaluation for a potentially clinically-significant illness (other than HCV) are also excluded.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Gastrointestinal disorder or post-operative condition that could interfere with the absorption of the study drug.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Difficulty with blood collection and/or poor venous access for the purposes of phlebotomy.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Clinical hepatic decompensation (i.e., ascites, encephalopathy or variceal hemorrhage).",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Solid organ transplantation.",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "64",
    "trial_id": "NCT02468648",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}